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Abstract
MITF is a basic-helix-loop-helix-leucine zipper-type transcription factor. 
The mutant mi  and  Mi
wh alleles encode MITFs with deletion and alteration 
of a single amino acid, respectively, while the tg is a null mutation. In 
coculture with NIH/3T3 fibroblasts, numbers of cultured mast cells 
(CMCs) derived from C57BL/6 (B6)-mi/mi, B6-Mi
wh/Mi
wh and B6-tg/tg
mice that adhered to NIH/3T3 fibroblasts were one third that of B6-+/+ 
CMCs. We subtracted a cDNA library of B6-+/+ CMCs with messenger 
RNAs expressed by B6-mi/mi CMCs and found a clone encoding SgIGSF, 
a recently identified member of the immunoglobulin superfamily. Northern 
and Western blot analyses revealed that SgIGSF was expressed in B6-+/+ 
CMCs but not in CMCs derived from MITF mutants.  
Immunocytochemical analysis showed that SgIGSF localized to the
cell-to-cell contact areas between B6-+/+ CMCs and NIH/3T3 fibroblasts. 
Transfection of B6-mi/mi and B6-tg/tg CMCs with SgIGSF cDNA 
normalized their adhesion to NIH/3T3 fibroblasts. NIH/3T3 fibroblasts did 
not express SgIGSF, indicating that SgIGSF acts as a heterophilic adhesion 
molecule. Transfection of B6-tg/tg CMCs with normal MITF cDNA 
elevated their SgIGSF expression to normal levels. These results indicated 
that SgIGSF mediated the adhesion of CMCs to fibroblasts and that the 
transcription of SgIGSF was critically regulated by MITF.
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Introduction
The mouse mi  locus  encodes a transcription factor belonging to the 
basic-helix-loop-helix - leucine zipper family denoted hereafter as the 
microphthalmia transcription factor (MITF).
1,2 The mutant mi allele 
produces an abnormal MITF protein that lacks one out of the four 
consecutive arginines in the basic domain (denoted hereafter as 
mi - MITF).
1,3,4 The mi-MITF is defective in DNA binding, nuclear 
translocation, and transactivation of target genes.
5-8 Another mutant allele is 
the tg allele, which is the MITF gene bearing a transgene insertion mutation 
in its 5’ flanking region.
1,9 Although the coding region of the MITF gene in 
C57BL/6 (B6)-tg/tg mice is normal, significant amounts of MITF were not 
detectable in cultured mast cells (CMCs) derived from the spleen of 
B6-tg/tg mice.
10
Both B6-mi/mi and B6-tg/tg mice show microphthalmia, lack of 
melanocytes and a decrease in skin mast cells.
11 B6-mi/mi mice show 
osteopetrosis but B6-tg/tg mice do not.
12 Most B6-mi/mi mice die upon 
weaning due to the failure of teeth eruption caused by the osteopetrosis, 
whereas most B6-tg/tg mice survive to adulthood. Mast cell numbers in 
skin tissues were comparable between B6-mi/mi and B6-tg/tg mice.
13
However, only B6-mi/mi mice showed a decrease of heparin content in skin 
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mast cells.
14
Gene expression profiles of CMCs were compared between B6-mi/mi and 
B6-tg/tg mice. The transcription of mouse mast cell protease (mMCP)-2, 
mMCP-4, mMCP-5, mMCP-6 and mMCP-9 genes decreased severely in 
both B6-mi/mi CMCs and B6-tg/tg CMCs.
15-18 The transcription of the 
genes encoding c-kit receptor tyrosine kinase (KIT), granzyme B, 
tryptophan hydroxylase, and N-deacetylase/N-sulfotransferase 2 was 
reduced severely in B6-mi/mi CMCs, but the reduction of transcription of 
these genes was not so severe in B6-tg/tg CMCs.
8,13,19 This indicated that 
the mi-MITF possessed an inhibitory effect on the transcription of KIT,
 19
granzyme B, tryptophan hydroxylase and N-deacetylase/N-sulfotransferase 
2 genes.
 8,13,19
We have shown that B6-mi/mi CMCs have a variety of abnormal 
phenotypes.
5-8 One is that they adhere poorly to fibroblasts.
20 A 
considerable number of B6-+/+ CMCs cultured on a monolayer of 
fibroblasts adhere to the fibroblasts,
20 - 22 but significantly fewer B6-mi/mi
CMCs do this.
20 In the present study, we examined the number of B6-tg/tg
CMCs that adhered to NIH/3T3 fibroblasts. We also assessed the adherence 
to fibroblasts of CMCs derived from B6-Mi
wh/Mi
wh mice, which have a 
single altered amino acid in the basic domain of MITF.
23 We found that 
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B6-tg/tg and B6-Mi
wh/Mi
wh CMCs were as poor as B6-mi/mi CMCs in 
adhering to fibroblasts. We subtracted a cDNA library of B6-+/+ CMCs 
with messenger RNAs expressed by B6-mi/mi CMCs. By screening the 
subtracted cDNA library, we identified a new mast cell adhesion molecule, 
SgIGSF (Spermatogenic Immunoglobulin Superfamily),
24 whose 
transcription was critically regulated by normal MITF (+-MITF) in CMCs. 
The deficient transcription of SgIGSF appeared a cause of the defective 
adhesion of CMCs derived from MITF mutant mice to NIH/3T3 
fibroblasts.
Materials and methods
Mice
The original stock of B6-mi/+ and B6-Mi
wh/+ mice was purchased from the 
Jackson Laboratory (Bar Harbor, ME). VGA-9-tg/tg mice were kindly provided
by Dr. H. Arnheiter (National Institute of Health, Bethesda, MD). All MITF 
mutant mice were maintained by consecutive backcrosses to our own inbred B6
colony (more than 12 generations at the time of the present experiment). 
Homozygous mice were produced by crosses between female and male 
heterozygotes of each genotype and selected by their white coat color. The 
WB-+/+, WB-W/W, WBB6F1-+/+ and WBB6F1-W/W
v mice were purchased 
from the Japan SLC (Hamamatsu, Japan).
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Cells
Spleens from 2 to 3-week-old mice were passed through first a 23-gauge needle, 
and were cultured in ￿-minimal essential medium (￿-MEM; ICN Biomedicals, 
Costa Mesa, CA) supplemented with 10% pokeweed mitogen-stimulated spleen 
cell-conditioned medium (PWM-SCM) and 10% fetal calf serum (FCS; Nippon 
Biosupp Center, Tokyo, Japan). PWM-SCM was prepared as described 
previously.
25 Half of the medium was replaced every 7 days. Four weeks later, 
more than 95% of the cells were CMCs. To examine growth kinetics of CMCs, 
2.5 x 10
5 CMCs were suspended in 2 ml ￿-MEM supplemented with 10% 
PWM-SCM and 10% FCS and plated onto 35-mm culture dishes. Various days 
after the plating, total cell numbers were counted with a standard 
hemocytometer. MST mastocytoma cells
26 were kindly provided by Dr. J. D. 
Esko (University of California, San Diego, CA). ￿2 helper virus-free 
packaging cells, NIH/3T3 mouse fibroblastic cells and Jurkat lymphoid cells 
were maintained as described previously.
19,27,28
Coculture of CMCs with fibroblasts and evaluation of attachment
Coculture of CMCs with NIH/3T3 cells was performed as described 
previously.
21,22 Briefly, CMCs (1.0 x 10
5 cells per dish) were suspended in 2 ml 
￿-MEM containing 10% FCS and added to a confluent culture of NIH/3T3 cells 
in 35-mm culture dishes. In some experiments, PWM-SCM was added to a 
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concentration of 10%. After 3 hours of coculture, the dishes were washed with 
warmed (37
oC) ￿-MEM to remove nonadherent CMCs. NIH/3T3 cells and 
adherent CMCs were harvested by trypsin treatment. These cells were attached 
to microscope slides using the Cytospin 2 centrifuge, fixed with Carnoy’s 
solution, and stained with alcian blue and nuclear fast red. The proportion of 
alcian blue-positive mast cells to alcian blue-negative NIH/3T3 cells was 
determined. Each experiment was done in triplicate and repeated three times 
with similar results.
cDNA libraries and isolation of clones 
A cDNA library of B6+/+ CMCs and the (+/+ - mi/mi) subtracted cDNA library 
were constructed previously.
7,29 Sequencing and isolation of clones from the 
libraries were performed as described previously.
7,27 The DNA sequences were 
used to search the National Center for Biotechnology Information database 
using the BLASTN algorithm.
Northern blotting and hybridization was performed using standard methods. 
Relative signal intensity was calculated with the BAS 2000 system (Fuji Photo 
Film Co., Tokyo, Japan). cDNA inserts of clones from the libraries and the 
￿-actin cDNA fragment
7 were labeled with [￿-
32P] dCTP by the random 
labeling method.
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Antibodies
A rabbit polyclonal antibody against SgIGSF was made in Kanazawa 
University (by T. W. and S. I.). The method of preparation and the sensitivity of 
the antibody are described in detail elsewhere (T. Wakayama and S Iseki, 
manuscript submitted). Briefly, rabbits were immunized against the synthetic 
polypeptide containing 15 amino acids of the C-terminus of SgIGSF. Four 
months later, the rabbit sera were purified with an affinity column containing 
the synthetic polypeptide. The anti-MITF antibody has been described
previously.
30 Other primary antibodies used are specific for KIT (M-14; Santa 
Cruz Biotechnology, Santa Cruz, CA), E-cadherin (Clone 36; Transduction 
Laboratories, Lexington, KY), N-cadherin (Clone 32; Transduction 
Laboratories), ICAM-1 (KAT-1; Seikagaku Corporation, Tokyo, Japan), integrin 
￿3 (Transduction laboratories), and ￿-tubulin (DM 1A; Sigma Chemical Co, St 
Louis, MO). Secondary antibodies used are peroxidase-labeled anti-rabbit, 
anti-mouse, or anti-rat IgG antibodies (MBL Co. Ltd., Nagoya, Japan), and 
fluorescein isothiocyanate (FITC)-labeled anti-rabbit IgG antibody (MBL Co. 
Ltd.).
Western blot analysis
CMCs and mouse tissues were lysed in a buffer containing 50 mM Tris-HCl 
(pH 8.0), 150 mM NaCl, 1% Triton X-100, and 1 mM phenylmethylsulfonyl 
fluoride. The resulting lysates were separated on 10% SDS-polyacrylamide gels, 
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transferred to Immobilon (Millipore, Bedford, MA), and reacted with the 
primary antibodies indicated. After washing, the blots were incubated with an 
appropriate peroxidase-labeled secondary antibody, and then reacted with 
Renaissance reagents (NEN, Boston, MA) before exposure. After stripping, the 
blots were probed with the anti-￿-tubulin antibody.
Enzymatic digestion of N-linked glycosylation
A 20-µl volume of CMC pellet was denatured at 100
oC for 10 minutes and then
one tenth of the sample was incubated at 37
oC for 1 hour in the presence or 
absence of Peptide:N-glycocidase F (PNGase F) (500 Unit) according to kit
instructions (New England Biolabs, Beverly, MA). The samples were then 
separated on SDS-polyacrylamide gels and reacted with the anti-SgIGSF 
antibody.
Transfection of CMCs with retroviral vector
The pCX4bsr vector, a modified pCXbsr vector,
31 was kindly provided by Dr. T. 
Akagi (Osaka Bioscience Institute, Osaka, Japan). A clone containing 
full-length SgIGSF cDNA was isolated from the B6-+/+ CMC cDNA library. 
The cDNA insert was excised by EcoRI digestion and inserted directionally into 
the pCX4bsr retroviral vector via the EcoRI site. The resulting 
pCX4bsr-SgIGSF vector or the empty pCX4bsr vector was then transfected into 
the packaging cell line￿2, and blasticidin-resistant ￿2 cell clones were selected 
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by culturing in ￿-MEM containing 10% FCS and blasticidin (3µg/ml; 
Invitrogen, Carlsbad, CA). To obtain infected CMCs, a subconfluent monolayer 
of the ￿2 cell clones that produce high titers of retrovirus containing either the 
SgIGSF cDNA or no insert was ￿-irradiated at a single dose of 30 Gy. A freshly 
prepared spleen cell suspension was then added onto the monolayer and 
incubated for 5 days in ￿-MEM containing 10% FCS and 10% PWM-SCM. 
Blasticidin-resistant CMCs were selected by continuing the culture in the 
presence of blasticidin (1.5 µg/ml) for 4 weeks. Transfection of CMCs with a 
retrovirus vector containing the +-MITF cDNA was performed as described 
previously.
19
NIH/3T3 cells were transfected with the pCX4bsr-SgIGSF vector by the 
calcium phosphate co-precipitation method. Blasticidin-resistant NIH/3T3 cells 
were selected by continuing the culture in the presence of blasticidin (3 µg/ml) 
for 4 weeks.
Immunocytochemistry
CMCs were washed with phosphate-buffered saline (PBS, pH 7.4), attached to 
microscope slides by Cytospin 2 centrifugation, and fixed with methanol. For 
staining the coculture, an NIH/3T3 monolayer was established on a coverslip 
placed at the bottom of a culture dish and CMCs were plated over this. After 
3-hour coculture, the coverslips were washed with PBS, and fixed with 
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methanol. Fixed samples were blocked with 2% bovine serum albumin in PBS, 
and incubated with the anti-SgIGSF antibody and stained with FITC-labeled 
anti-rabbit IgG antibody. For double staining with phalloidin, the coculture 
samples were fixed with 3.7% paraformaldehyde in PBS, and permeabilized 
with 0.1% Triton X-100 in PBS. After staining with the anti-SgIGSF antibody 
as described above, the samples were incubated with tetramethylrhodamine 
isothiocyanate (TRITC)-labeled phalloidin (1:5,000 dilution; Sigma). Cells 
were visualized using a confocal laser scanning microscope (LSM510; Carl 
Zeiss, OberKochen, Germany).
Luciferase assay
The pEF-BOS vectors
32 containing +-MITF or mi - MITF cDNA were 
constructed previously
19 and used as effectors. The 5’ flanking sequence of the 
SgIGSF gene was obtained from the database of the Celera Discovery System 
(Celera, Rockville, MD). The genomic region of nt -1501  to + 19 of the SgIGSF 
gene was amplified by PCR and subcloned into the upstream region of the 
luciferase gene in pSPLuc plasmid. A reporter and an effector were 
electroporated together into MST mastocytoma and Jurkat lymphoid cells as 
described previously.
13,27 The relative luciferase activity was calculated as 
described previously.
7
Electrophoretic gel mobility shift assay (EGMSA)
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GST and GST-+-MITF were produced previously.
5 Two oligonucleotides were 
synthesized: E, 5’-GCTTTAATGTGTAACTCATTTGATGGGTTGGCCGA-3’ 
[nucleotide (nt) -1506 to -1472 of the SgIGSF promoter], and mE, 
5’-GCTTTAATGTGTAACTCTTTAGATGGGTTGGCCGA-3’. EGMSA was 
performed as described previously.
7
Results
Poor attachment of CMCs derived from MITF mutants to NIH/3T3 
fibroblasts
We examined numbers of B6-+/+, B6-mi/mi, B6-tg/tg and B6-Mi
wh/Mi
wh CMCs 
that adhered to NIH/3T3 cells 3 hours after the initiation of the coculture. The 
number of adhering B6-mi/mi, B6-tg/tg or B6-Mi
wh/Mi
wh CMCs was one third 
that of B6-+/+ CMCs (Table 1). No significant difference was observed among 
numbers of adhering B6-mi/mi, B6-tg/tg and B6-Mi
wh/Mi
wh CMCs. As we 
reported previously,
20 addition of PWM-SCM to the coculture did not affect the 
results (Table 1).
Isolation of SgIGSF gene as a transcriptionally downregulated gene in 
B6-mi/mi CMCs
We constructed a cDNA library from B6-+/+ CMCs, and subtracted it with 
mRNAs expressed in B6-mi/mi CMCs.
7 The (+/+ - mi/mi) subtracted cDNA 
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library proved to be enriched with clones that were transcriptionally 
downregulated in B6-mi/mi CMCs.
7,8 From the subtracted library, we attempted 
to isolate cDNA clones whose gene product may explain the deficient adhesion 
of B6-mi/mi and B6-tg/tg CMCs to NIH/3T3 cells. We sequenced 
approximately 600 clones from the library, and found a clone (#236) that 
carried part of the cDNA sequence encoding SgIGSF (Spermatogenic 
Immunoglobulin Superfamily). The cDNA of SgIGSF was recently cloned from 
mouse testes, and has a putative transmembrane domain and an extracellular 
domain consisting of three immunoglobulin-like loops.
24
We performed Northern blot analysis on RNAs extracted from B6-+/+,
B6-mi/mi and B6-tg/tg CMCs using clone #236 as a probe. Two transcripts 
were detected near the positions of 28S and 18S in B6-+/+ CMCs: the 
expression of the longer transcript was much stronger than that of the shorter 
one (Figure 1A). This result was consistent with the result reported by 
Wakayama et al
24 that the SgIGSF gene has two transcripts of 4.5 and 2.1 kb in 
mouse testes. In contrast to the case of B6-+/+ CMCs, no hybridization signals 
were detected in RNAs obtained from either B6-mi/mi or B6-tg/tg CMCs 
(Figure 1A). We screened the original cDNA library of B6-+/+ CMCs by using 
clone #236 as a probe, and isolated 5 positive clones carrying a ~ 2.1 kb cDNA 
insert. Sequencing revealed that the cDNA inserts of all clones were identical to 
the reported full-length cDNA of the SgIGSF gene (accession no. AB052293).
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Protein expression of SgIGSF was examined by blotting the lysates of CMCs 
from various genotypes with the anti-SgIGSF antibody (Figure 1B). Two strong 
bands of ~ 110 and ~ 38 kDa and a weak band of ~ 50 kDa were observed in the 
B6-+/+ CMC lysate. In the lysates of B6-mi/mi, B6-tg/tg and B6-Mi
wh/Mi
wh
CMCs, ~ 110 and ~ 38 kDa bands were not detectable but the ~ 50 kDa band 
was recognizable (Figure 1B).
Western blotting was also performed on the lysates of intact NIH/3T3 cells and 
NIH/3T3 cells that had been transfected with full-length SgIGSF cDNA. No 
band was observed in the lysate of intact NIH/3T3 cells. In the transfected 
NIH/3T3 cells, four bands were recognized, and the bands representing the 
longest and shortest proteins were positioned at mobility sizes similar to those 
of the two strong bands observed in B6-+/+ CMCs (Figure 1B). Thus, we 
considered that SgIGSF had two forms of ~ 110 and ~ 38 kDa in B6-+/+ CMCs, 
but these forms were absent from B6-mi/mi, B6-tg/tg and B6-Mi
wh/Mi
wh CMCs. 
A weak band of ~ 50 kDa detected in all four types of CMCs remained 
uncharacterized. Since there is no SgIGSF mRNA expression in B6-mi/mi and 
B6-tg/tg CMCs, the ~ 50 kDa band appeared to arise from cross recognition of 
an unknown protein by the SgIGSF antibody rather than its specific recognition 
of another form of SgIGSF.
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We also examined the expression of several intercellular adhesion molecules in 
CMCs with mutant MITFs. Expression levels of E-cadherin, N-cadherin, 
ICAM-1 and integrin ￿3 in B6-mi/mi, B6-tg/tg and B6-Mi
wh/Mi
wh CMCs were 
comparable with those of B6-+/+ CMCs (Figure 1B).
CMCs were obtained from WB-+/+, WB-W/W, WBB6F1-+/+ and 
WBB6F1-W/W
v mice, and the expression of KIT and SgIGSF was examined 
using anti-KIT and anti-SgIGSF antibodies. KIT signals were detected in the 
lysates of B6-+/+, WB-+/+ and WBB6F1-+/+ CMCs, whereas no specific 
signals were found in the lysate of WB-W/W CMCs (Figure 2). In 
WBB6F1-W/W
v CMCs, KIT signals were detectable in significantly reduced 
levels (Figure 2). Next, the blot was reacted with the anti-SgIGSF antibody. 
WBB6F1-W/W
v CMCs expressed SgIGSF as abundantly as WBB6F1-+/+ CMCs, 
and WB-W/W CMCs expressed a rather higher level of SgIGSF than WB-+/+ 
CMCs did (Figure 2). In the lysates of CMCs from WB and WBB6F1 mice, the 
~ 50 kDa band was recognized much more strongly by the SgIGSF antibody 
than in the lysates of CMCs from B6 mice.
Tissue distribution of SgIGSF
We examined the expression of SgIGSF in various tissues of B6-tg/tg mice. 
Lysates of testes, spleens, lungs and stomachs were obtained from B6-+/+ 
and B6-tg/tg mice, and were blotted with the anti-SgIGSF antibody. In spite 
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of remarkable difference in SgIGSF expression between B6-+/+ and 
B6-tg/tg CMCs, the expression was comparable between testis, lung, spleen 
and stomach tissues of B6-+/+ and B6-tg/tg mice (Figure 3A).
When the lysate of +/+ CMCs was treated with PNGase F, the mobility size 
of the ~ 110 kDa SgIGSF decreased to ~ 70 kDa, indicating the heavy 
N-glycosylation (Figure 3B). On the other hand, the ~ 38 kDa form was not 
influenced by the PNGase F treatment. Similar results were obtained when 
the lysate of B6-+/+ testes were treated with PNGase F (Figure 3B). The 
variability of the molecular weights of SgIGSF observed in CMCs, NIH/3T3 
transfectants and tissues seemed to reflect the presence of various forms of 
SgIGSF that have received cell and tissue type-specific glycosylation.
Localization of SgIGSF
CMCs of various genotypes were cultured in suspension in the presence of 
PWM-SCM. Cytospin preparations of the suspension cultured CMCs were 
made and stained with anti-SgIGSF antibody. When aggregates of B6-+/+ 
CMCs were observed, the SgIGSF-specific fluorescence was detected in the
area of cell-to-cell contact (Figure 4A). The SgIGSF-specific fluorescence 
was not detectable in B6-+/+ CMCs that isolated from each other. Even 
when aggregates of B6-tg/tg CMCs were observed in cytospin preparations, 
no SgIGSF-specific fluorescence was detectable (Figure 4B). No 
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SgIGSF-specific fluorescence was observed in aggregated B6-mi/mi CMCs, 
either (data not shown).
We also examined the localization of SgIGSF in the coculture of CMCs and 
NIH/3T3 fibroblasts. CMCs of various genotypes were plated onto the 
monolayer of NIH/3T3 cells that had attached to a coverslip. After 3-hour 
coculture, the peripheral margin of B6-+/+ CMCs adhering to NIH/3T3 cells 
was clearly demarcated with the anti-SgIGSF antibody (Figure 4C). The 
peripheral margin of neither B6-tg/tg nor B6-mi/mi CMCs cocultured with 
NIH/3T3 cells was demarcated with the anti-SgIGSF antibody (data not 
shown). A sectional view of the coculture revealed that SgIGSF-specific 
fluorescence was concentrated on the lateral membrane of CMCs that faced 
the NIH/3T3 cells (Figure 4C). When the polymerized actin filaments in the
coculture of B6-+/+ CMCs and NIH/3T3 cells were visualized with 
phalloidin, densely stained actin filaments was detected in the peripheral 
margin of adhering B6-+/+ CMCs. These stains colocalized with SgIGSF
(Figure 4D to F). This indicated the localization of SgIGSF in lamellipodial 
structure. The immunocytochemical finding that NIH/3T3 cells were not 
stained with the anti-SgIGSF antibody was consistent with the result of 
Western blot analysis (Figures 1C and 4C).
Transfection of cDNAs encoding SgIGSF or +-MITF
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Spleen cells of B6-tg/tg and B6-mi/mi mice were cocultured with ￿2 
packaging cells transformed with the retrovirus vector containing the 
SgIGSF cDNA. As a control, B6-tg/tg spleen cells were cocultured with the 
packaging cells transformed with either the retrovirus vector containing the 
+-MITF cDNA or the empty vector. All four types of cocultures were 
maintained in the presence of PWM-SCM and the selective drug. Four 
weeks after the initiation of the coculture, >95% of the floating cells were 
CMCs in all four types of cocultures. Thus, coculture with the packaging 
cells did not influence the purity of CMCs.
Obtained CMCs were examined for their expression levels of SgIGSF by 
Western blot. Prominent expression of SgIGSF was detected in the lysates of 
B6-tg/tg and B6-mi/mi CMCs transfected with SgIGSF cDNA (Figure 5). 
When the band intensity was normalized with the immunoreactivity to the 
anti-tubulin antibody, the expression levels of SgIGSF in B6-tg/tg and 
B6-mi/mi CMCs transfected with SgIGSF cDNA were more than 10-fold 
higher than the level of B6-+/+ CMCs. When the protein samples were 
loaded equally per lane, the ~ 50 kDa band was detected in the lysates of 
B6-tg/tg and B6-mi/mi CMCs transfected with SgIGSF cDNA as strongly as 
observed in the lysates of B6-tg/tg and B6-mi/mi CMCs (data not shown). 
The expression level of SgIGSF in B6-tg/tg CMCs transfected with +-MITF 
cDNA was comparable with that of B6-+/+ CMCs (Figure 5). The blot was 
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probed again with the anti-MITF antibody. Although expression level of the 
endogenous +-MITF in B6-+/+ CMCs was below the limit of detection, the 
expression of +-MITF was detectable in B6-tg/tg CMCs transfected with 
+-MITF cDNA (Figure 5). Neither SgIGSF nor MITF expression was 
observed in the original B6-tg/tg CMCs and those transfected with the 
empty vector (Figure 5).
B6-tg/tg CMCs transfected with SgIGSF cDNA started forming macroscopic 
aggregates from four weeks after initiating the culture of B6-tg/tg spleen 
cells (Figure 6A and B). Similar aggregates were formed by B6-mi/mi CMCs 
transfected with SgIGSF cDNA (data not shown). On the other hand, 
B6-tg/tg CMCs transfected with +-MITF cDNA did not form such 
aggregates (data not shown). The appearance of B6-tg/tg CMCs transfected 
with +-MITF was similar to the appearance of B6-+/+ CMCs.
In the culture of B6-tg/tg and B6-mi/mi CMCs transfected with SgIGSF 
cDNA, both the number of aggregates and the number of cells in each 
aggregate continually increased after the fourth week of culture. In the fifth 
week of culture, the number of cells forming aggregates reached to more 
than half of total cells in each culture, and some aggregates contained more 
than 100 cells. The aggregated CMCs did not appear to grow as fast as intact 
B6-tg/tg and B6-mi/mi CMCs. When intact B6-tg/tg and B6-mi/mi CMCs 
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were plated in fresh medium containing PWM-SCM, the total number of 
CMCs increased nearly 3-fold after a week (Figure 7). In contrast, there was 
only a 50% increase in the total cell number of B6-tg/tg and B6-mi/mi
CMCs transfected with SgIGSF after a week (Figure 7).
Cytospin preparations of B6-tg/tg CMCs transfected with SgIGSF cDNA or 
with +-MITF cDNA were stained with anti-SgIGSF antibody. The plasma 
membranes of aggregated SgIGSF-transfected B6-tg/tg CMCs were strongly 
immunoreactive to the anti-SgIGSF antibody (Figure 6C). The 
SgIGSF-specific fluorescence was restricted to the cell-to-cell contact areas. 
Although B6-tg/tg CMCs transfected with +-MITF cDNA did not form 
macroscopic aggregates, microscopic aggregates of CMCs were detectable 
in cytospin preparations. SgIGSF-specific fluorescence was detected in the 
cell-to-cell contact areas of these aggregated cells, as with the B6-+/+ CMCs 
(compare Figure 6D to Figure 4A). The SgIGSF-specific fluorescence was 
significantly stronger in SgIGSF-transfected B6-tg/tg CMCs than in 
+-MITF-transfected B6-tg/tg CMCs. The result of immunostaining of 
B6-mi/mi CMCs transfected with SgIGSF cDNA was similar to that of 
B6-tg/tg CMCs transfected with SgIGSF cDNA (data not shown).
Normalization of the adhesion of MITF mutant-derived CMCs to NIH/3T3 
cells by transfection with SgIGSF or +-MITF
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Single cell suspension was prepared by pipetting aggregates of 
SgIGSF-transfected B6-tg/tg and B6-mi/mi CMCs. The resulting single cell 
suspension of B6-tg/tg and B6-mi/mi CMCs transfected with SgIGSF cDNA 
and the single cell suspension of B6-tg/tg CMCs transfected with +-MITF 
cDNA were added to the monolayer of NIH/3T3 cells. After three hours of
coculture, we counted the number of adhering CMCs per NIH/3T3 cell. Not 
only +-MITF-transfected B6-tg/tg CMCs but also SgIGSF-transfected 
B6-tg/tg and B6-mi/mi CMCs adhered to NIH/3T3 cells as frequently as 
B6-+/+ CMCs (Table 2).
Transcriptional activation of the SgIGSF gene by +-MITF
We examined the effect of +-MITF and mi-MITF on the transcription of the 
SgIGSF gene using the transient cotransfection assay. The 5’-flanking 
sequence of the SgIGSF gene [nt -1501 to +19 (+1 is the transcription start 
site)] was cloned upstream of the luciferase gene. This construct was 
cotransfected into MST mastocytoma cells with an empty pEF-BOS plasmid
or with the vectors expressing either +-MITF or mi - MITF. Cotransfection 
with the +-MITF cDNA increased the luciferase activity 3-fold as strongly 
as cotransfection with the empty vector, but cotransfection with mi - MITF 
cDNA did not increase the luciferase activity (Figure 8A, upper).
Previously we reported that +-MITF directly transactivated a number of 
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genes by binding to CANNTG motifs.
7,17,18 The region between nt -1501 and 
+19 of the SgIGSF gene contained two CANNTG motifs: CATTTG (nt 
-1490 to -1485) and CACTTG (nt -682 to -677). We mutated the CATTTG 
(nt -1490 to -1485) motif to CTTTAG and found that the mutation abolished 
the transactivation effect of +-MITF (Figure 8A, upper). Next, we deleted 
the CATTTG (nt -1490 to -1485) motif from the SgIGSF promoter. The 
resulting shorter luciferase construct, which contained only the CACTTG (nt 
-682 to -677) motif, was not transactivated by cotransfection with the 
+-MITF cDNA (Figure 8A, upper).
We performed similar luciferase assays using Jurkat lymphoid cells instead 
of MST cells. Neither +-MITF nor mi - MITF produced any transactivation 
effects on the three luciferase constructs (Figure 8A, lower).
We examined in vitro binding of +-MITF to the CATTTG motif by EGMSA.
Two oligonucleotides containing the CATTTG (nt -1490 to -1485; 
oligonucleotide E) and mutated (CTTTAG; oligonucleotide mE) motifs were 
synthesized. When oligonucleotide E was incubated with the GST-+-MITF 
fusion protein, a slowly migrating band was detected (Figure 8B, lane 2). 
The band appeared to be due to the specific binding of oligonucleotide E to 
+-MITF but not to GST, because incubation of this oligonucleotide with the 
GST protein alone did not yield any bands (Figure 8B, lane 1). To examine 
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whether the binding between oligonucleotide E and GST-+-MITF was 
dependent on the CATTTG motif, the binding reaction was performed in the 
presence of an excess amount of unlabeled competitors. The binding of 
labeled oligonucleotide E to GST-+-MITF was completely competed out by 
adding an excess amount of unlabeled oligonucleotide E, but not by adding 
the same amount of unlabeled oligonucleotide mE (Figure 8B, lanes 3 and 4).
Discussion
In the present study, we examined cell-to-cell adhesion phenotypes of CMCs 
derived from three MITF mutants, B6-tg/tg, B6-mi/mi and B6-Mi
wh/Mi
wh
mice. The mi  and  Mi
wh mutant alleles encode MITFs with deletion 
(mi - MITF)
1,3,4 and alteration (Mi
wh-MITF)
23 of a single amino acid at the 
basic domain, respectively,
4 whereas tg is a null mutation.
1,9,10 The mi - MITF 
has a significant inhibitory effect on transcription of various genes.
8,13,19 The 
Mi
wh-MITF have a decreased but detectable transcription activity on some 
genes and also an inhibitory effect on other genes.
23,33 Although these mutant 
alleles have different structural and functional abnormalities, poor adhesion 
of CMCs to NIH/3T3 fibroblasts was common among CMCs derived from 
all three MITF mutant mice.
By screening the (+/+ - mi/mi) subtracted cDNA library, we identified 
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SgIGSF as a transcriptionally downregulated gene in B6-mi/mi CMCs. 
SgIGSF is a member of the immunoglobulin superfamily that was recently 
cloned from the cDNA library of adult mouse testes. Wakayama et al
24
showed that SgIGSF was preferentially expressed by spermatogenic cells 
and suggested that SgIGSF may participate in the interaction of 
spermatogenic cells with Sertoli cells. Expression of SgIGSF was readily 
detectable in B6-+/+ CMCs, but not in CMCs derived from three examined 
MITF mutant mice.
A human homologue of SgIGSF is known as IGSF4 (immunoglobulin 
superfamily number 4
34): there is 98% identity between both molecules at 
amino acid levels. Both SgIGSF and IGSF4 have an extracellular domain 
with significant homology to NCAM-1 (neural cell adhesion molecule-1) 
and NCAM-2.
24 A putative motif sequence that connects to actin 
cytoskeleton was present in the intracellular domain of SgIGSF and 
IGSF4.
35 Recently, IGSF4 was found to be identical to TSLC1 (tumor 
suppressor in lung cancer-1).
36,37 TSLC1 was originally cloned from the 
genomic region that frequently exhibits loss of heterozygosity in human lung 
cancers and possesses a tumor-suppressor activity. A recent study of Masuda 
et al
38 showed that TSLC1/IGSF4 localized to the plasma membrane in 
cell-to-cell contact areas and that cells overexpressing TSLC1/IGSF4 more 
frequently formed aggregates. SgIGSF as well as TSLC1/IGSF4 appeared to 
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mediate intercellular adhesion.
Immunofluorescence analysis of cytospin preparations showed that the 
subcellular localization of SgIGSF was restricted to cell-to-cell contact areas 
among B6-+/+ CMCs. This localization pattern was common not only to 
TSLC1/IGSF4
38 but also to well-characterized intercellular adhesion 
molecules, such as E-cadherin and nectins.
39,40 In B6-+/+ CMCs adhering to 
NIH/3T3 fibroblasts, SgIGSF located primarily in the lamellipodial structure, 
where cytoskeletal components and regulators, such as vinculin and Rac-1, 
are known to accumulate in mast cells.
41 These results suggested that 
SgIGSF may mediate the adhesion either among CMCs or between CMCs 
and NIH/3T3 fibroblasts.
Consistent with the results of immunofluorescence, overexpression of 
SgIGSF in B6-tg/tg and B6-mi/mi CMCs resulted in the formation of 
macroscopic aggregates in suspension culture, although intact B6-tg/tg and 
B6-mi/mi CMCs did not form such aggregates. SgIGSF appeared to function 
as a homophilic adhesion molecule. But, this homophilic interaction may 
take place only when SgIGSF is overexpressed. In fact, B6-+/+ CMCs did 
not form such macroscopic aggregates.
B6-tg/tg and B6-mi/mi CMCs overexpressing SgIGSF adhered to NIH/3T3 
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fibroblasts as well as B6-+/+ CMCs, although original B6-tg/tg and 
B6-mi/mi CMCs did not. This indicates that SgIGSF is necessary for 
adhesion of CMCs to NIH/3T3 fibroblasts. Since NIH/3T3 fibroblasts did 
not express SgIGSF, SgIGSF appeared to serve as a heterophilic adhesion 
molecule in the interaction between CMCs and NIH/3T3 fibroblasts. The 
counterpart of SgIGSF that is expressed by NIH/3T3 fibroblasts remains to 
be identified. Probably the heterophilic interaction may be more 
physiological than the homophilic interaction, because the overexpression of 
SgIGSF was not necessary for the heterophilic interaction.
Expression levels of the SgIGSF protein were not reduced in CMCs derived 
from WB-W/W and WBB6F1-W/W
v mice. The W allele encodes the mutant 
KIT without the extracellular domain,
42 and the W
v allele the mutant KIT 
with an intact extracellular domain and a mutated tyrosine kinase domain.
43
In the coculture with NIH/3T3 fibroblasts, WBB6F1-W/W
v CMCs normally 
adhered to NIH/3T3 fibroblasts, whereas WB-W/W CMCs did not.
44 Since 
WB-W/W CMCs expressed SgIGSF, their deficient adhesion to NIH/3T3 
fibroblasts was attributable to the deficient expression of the extracellular 
domain of KIT. On the other hand, B6-mi/mi, B6-tg/tg and B6-Mi
wh/Mi
wh
CMCs did not adhere to NIH/3T3 fibroblasts. Although B6-mi/mi and 
B6-tg/tg CMCs showed deficient expression of KIT,
8 B6-Mi
wh/Mi
wh CMCs 
did show normal expression level of KIT.
23 Therefore, the deficient adhesion 
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of CMCs of MITF mutants was attributable to the deficient expression of 
SgIGSF. Both KIT and SgIGSF appeared necessary for adhesion of CMCs to 
NIH/3T3 fibroblasts.
Defective expression of SgIGSF in CMCs derived from all MITF mutant 
mice suggested that the presence of +-MITF was essential for the expression 
of SgIGSF in mast cells. However, +-MITF did not appear necessary for the 
expression of SgIGSF in cells other than mast cells. In fact, the expression of 
SgIGSF was comparable between testes, spleens, lungs and stomachs of 
B6-+/+ and B6-tg/tg mice. Probably, other transcription factors may 
compensate +-MITF in these tissues. The transactivation effect of +-MITF 
on the SgIGSF gene promoter was detected in MST mastocytoma cells but 
not in Jurkat lymphoid cells. In addition, transfection with the +-MITF 
cDNA normalized the expression of SgIGSF in B6-tg/tg CMCs. The 
transactivation of +-MITF was mediated through CATTTG motif (nt -1490 
to -1485) in the promoter region of the SgIGSF gene at least in mast cells.
Taken together, we identified a new mast cell adhesion molecule, SgIGSF. 
Transcription of the SgIGSF gene was critically regulated by +-MITF in 
mast cells. SgIGSF appeared to mediate not only the aggregation of CMCs 
through its homophilic interaction, but also the adhesion of CMCs to 
NIH/3T3 fibroblasts through its heterophilic interaction.
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Table 1. Poor attachment of B6-mi/mi, B6-tg/tg and B6-Mi
wh/Mi
wh CMCs to 
NIH/3T3 fibroblasts
No. of adhering CMCs per NIH/3T3 cell *
Genotype of CMCs
PWM-SCM(-) 
† PWM-SCM(+) 
†
+/+      0.166 r 0.021      0.162 r 0.028
mi/mi      0.042 r 0.017 
‡      0.044 r 0.022 
‡
tg/tg      0.044 r 0.010 
‡      0.048 r 0.023 
‡
Mi
wh/Mi
wh      0.040 r 0.011 
‡      0.046 r 0.012 
‡
* Mean and SE of three dishes.
† The coculture of CMCs and NIH/3T3 cells was done with (+) or without (-) 
PWM-SCM (10%).
‡ P <0.01 by t-test when compared with the values of B6-+/+ CMCs.
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Table 2. Normalization of attachment of B6-tg/tg and B6-mi/mi CMCs to 
NIH/3T3 fibroblasts by transfection with SgIGSF or +-MITF cDNA
CMCs No. of adhering CMCs per NIH/3T3 cell *
   +/+ CMCs            0.163 r 0.006
tg/tg CMCs            0.053 r 0.006 
†
tg/tg CMCs transfected with SgIGSF   0.189 r 0.026
tg/tg CMCs transfected with +-MITF            0.169 r 0.017
tg/tg CMCs transfected with vector            0.057 r 0.005 
†
mi/mi CMCs            0.045 r 0.005 
†
mi/mi CMCs transfected with SgIGSF            0.156 r 0.029
* Mean and SE of three dishes.
† P <0.01 by t-test when compared with the values of B6-+/+ CMCs.
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Figure 1. Expression of SgIGSF and intercellular adhesion molecules in 
MITF mutant-derived CMCs. (A) Expression of SgIGSF mRNA in B6-+/+, 
B6-mi/mi and B6-tg/tg CMCs. Ten µg of total RNA from CMCs of three 
genotypes were electrophoresed and hybridized with the clone #236 probe. 
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After stripping, the blot was hybridized with the ￿-actin probe to indicate the 
amount of RNA loaded per lane. (B) Expression of the SgIGSF protein and 
intercellular adhesion molecules in B6-+/+, B6-mi/mi, B6-tg/tg and 
B6-Mi
wh/Mi
wh CMCs. The lysates of the indicated cells were electrophoresed 
and blotted with antibodies against SgIGSF, E-cadherin, N-cadherin, ICAM-1 
and integrin ￿3. The molecular weight scale is shown to the right of the blots. 
(C) Western blot analysis of NIH/3T3 cells and those transfected with SgIGSF 
cDNA (NIH/3T3
SgIGSF). The lysates of the indicated cells were electrophoresed 
and blotted with the SgIGSF antibody and then probed again with the 
anti-￿-tubulin antibody to indicate the total amount of proteins loaded per lane. 
The molecular weight scale is shown to the right of the blot.
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Figure 2. SgIGSF expression in CMCs derived from KIT mutant mice. The 
lysates were prepared from CMCs derived from mice of the indicated genotypes, 
and were blotted with the anti-KIT and anti-SgIGSF antibodies. The molecular 
weight scale is shown on the right of the blots. The blots were probed again 
with the anti-￿-tubulin antibody to indicate the total amount of proteins loaded 
per lane.
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Figure 3. SgIGSF expression in various tissues of B6-tg/tg mice. (A) 
Expression of the SgIGSF protein in the testis, lung, spleen and stomach tissues 
of B6-+/+ and B6-tg/tg mice. Lysates were prepared from the indicated tissues 
and were blotted with the anti-SgIGSF antibody. (B) N-linked glycosylation of 
SgIGSF proteins in B6-+/+ CMCs and testes. Lysates of B6-+/+ CMCs and 
testes were incubated at 37
oC for 1 hour in the presence (+) or absence (-) of 
PNGase F and blotted with the anti-SgIGSF antibody. The molecular weight 
scale is shown to the right of the blots. The blots were probed again with the 
anti-￿-tubulin antibody to indicate the total amount of proteins loaded per lane.
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Figure 4. Immunolocalization of SgIGSF in CMCs. Immunocytochemical 
analysis of B6-+/+ (A) and B6-tg/tg (B) CMCs. Cytospin preparations of CMCs 
were fixed with methanol, reacted with the anti-SgIGSF antibody, and stained 
with FITC-labeled secondary antibody. Bar, 10 µm. (C) Immunocytochemical 
analysis of the coculture of B6-+/+ CMCs and NIH/3T3 cells. CMCs were 
cocultured on the monolayer of NIH/3T3 cells for 3 hours. The coculture was 
fixed with methanol, reacted with the anti-SgIGSF antibody, and stained with 
FITC-labeled antibody. A representative set of X-Y and Y-Z sections is shown. 
A red line indicates the plane of the Y-Z section. Asterisks and sharps indicate 
B6-+/+ CMCs and NIH/3T3 cells, respectively. Bar, 10 µm. (D-F) 
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Colocalization of SgIGSF with polymerized actin filaments in the peripheral 
margin of B6-+/+ CMCs that have adhered to NIH/3T3 cells. After coculturing 
CMCs on the monolayer of NIH/3T3 cells for 3 hours, the coculture was fixed 
with paraformaldehyde, reacted with the anti-SgIGSF antibody, and stained 
with FITC-labeled secondary antibody (D). Subsequently, the culture was 
stained with TRITC-labeled phalloidin (E) and the FITC and TRITC images 
were merged (F). Bar, 10 µm.
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Figure 5. Expression of the SgIGSF protein in B6-tg/tg and B6-mi/mi CMCs 
transfected with SgIGSF cDNA. B6-tg/tg CMCs were infected with the empty 
retroviral vector (tg/tg CMC
Vector) or the vector containing either SgIGSF cDNA 
(tg/tg CMC
SgIGSF) or +-MITF cDNA (tg/tg CMC
+-MITF). B6-mi/mi CMCs were 
infected with the vector containing the SgIGSF cDNA (mi/mi CMC
SgIGSF). The 
lysates of the indicated cells were electrophoresed and blotted with the 
anti-SgIGSF and anti-MITF antibodies. After stripping, the blot was probed 
with the anti-￿-tubulin antibody to indicate the total amount of proteins loaded 
per lane.
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Figure 6. Phenotypes of B6-tg/tg CMCs transfected with SgIGSF or 
+-MITF. (A) Phase contrast image of B6-tg/tg CMCs transfected with SgIGSF 
cDNA. Aggregates of the CMCs were floating in the medium. Bar, 50 µm. (B) 
Aggregates composed of numerous alcian blue-positive cells. Cytospin samples 
of B6-tg/tg CMCs transfected with SgIGSF cDNA were stained with alcian blue 
and nuclear fast red. Bar, 50 µm. (C and D) Immunocytochemical analysis of 
B6-tg/tg CMCs transfected with either SgIGSF cDNA (C) or +-MITF cDNA 
(D). Cytospin preparations of either type of cells were fixed with methanol, 
reacted with the anti-SgIGSF antibody, and stained with FITC-labeled 
secondary antibody. Bar, 10 µm.
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Figure 7. Growth kinetics of SgIGSF-transfected CMCs. 2.5 x 10
5 of CMCs 
were suspended in 2 ml of fresh medium containing PWM-SCM and plated 
onto 35-mm culture dishes. On the indicated days after the plating, total cell 
numbers were counted with a standard hemocytometer. Four types of CMCs 
were examined: B6-mi/mi CMCs, B6-tg/tg CMCs, B6-mi/mi CMCs transfected 
with SgIGSF cDNA (mi/mi CMC
SgIGSF), and B6-tg/tg CMCs transfected with 
SgIGSF cDNA (tg/tg CMC
SgIGSF). The mean cell numbers of triplicate samples 
were plotted with bars indicating SE. * P <0.01 by t-test when compared with 
the values of intact B6-mi/mi or tg/tg CMCs.
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Figure 8. Luciferase assay and EGMSA. (A) Transactivation of the SgIGSF 
promoter by +-MITF. The promoter sequences of the SgIGSF from -1501 to 
+19 were inserted upstream of the luciferase (LUC) gene of the pSPLuc vector. 
In one construct, the CATTTG motif in the promoter was mutated to CTTTAG 
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(indicated by X). The deletion construct lacking the CATTTG motif was also 
made. These reporter constructs were cotransfected into MST (upper) or Jurkat 
(lower) cells with the empty pEF-BOS vector or the vector containing either 
+-MITF or mi-MITF cDNA. The mean values of the luciferase activity obtained 
with triplicate samples were plotted with bars indicating SE. In most cases, the 
SE values were too small to be shown by bars. (B) In vitro binding between the 
CATTTG motif and +-MITF. Oligonucleotide E was labeled with [￿-
32P] dCTP 
and used as a probe. The unlabeled oligonucleotides E and mE were used as 
competitors. The probe was incubated with either GST or GST-+-MITF protein 
in the absence (-) or presence of an excess amount of either competitor. An 
arrow indicates a protein-DNA complex.
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